Please use this identifier to cite or link to this item:https://hdl.handle.net/20.500.12512/22494
Type of publication: conference paper
Type of publication (PDB): Tezės Clarivate Analytics Web of Science Master Journal List / Theses in Clarivate Analytics Web of Science Master Journal List (T1b)
Field of Science: Medicina / Medicine (M001)
Author(s): Undžytė, Greta;Patašius, Aušvydas;Stukas, Rimantas;Linkevičiūtė-Ulinskienė, Donata;Smailytė, Giedrė
Title: Increased risk of kidney cancer in a cohort of Lithuanian diabetes mellitus patients
Is part of: European Urology Supplements : 6th Baltic Meeting in conjunction with the EAU : 24 May 2019-25 May 2019, Tallinn, Harjumaa, Estonia / European Association of Urology (EAU). Amsterdam : Elsevier Science, 2019, vol. 18, iss. 3
Extent: p. e2506-e2506, no. 68
Date: 2019
Series/Report no.: (Conference abstract)
Note: ISSN 1569-9056 (Linking)
Keywords: Diabetes mellitus;complications;Kidney neoplasms;Risk factors;Cohort studies;Lithuania
Abstract: Introduction & Objectives: Diabetes is associated with increased risk of cancer at several sites, but its association with cancer of the kidney is unclear. We aimed to estimate kidney cancer risk in type 2 diabetic patients' in a large, population-based cohort study in Lithuania. Materials & Methods: The cohort was composed of diabetic patients identified in the National Health Insurance Fund database during 2000–2012. Cancer cases were identified by record linkage with the national Cancer Registry. Standardized incidence ratios (SIRs) for kidney cancer as a ratio of observed number of cancer cases in people with diabetes diagnosis to the expected number of cancer cases in the underlying general population was calculated. Results: 115923 patients diagnosed with type 2 diabetes mellitus between 2000 and 2012 were identified. Overall, 598 cases of primary kidney cancer were identified versus 393.95 expected within a period of observation yielding an overall SIR of 1.52 (95% CI: 1.40–1.64), significantly higher risk was found in both male and female diabetic patients in all age groups. Significantly higher risk of kidney cancer also was found in both metformin users and never-users’ groups (SIRs 1.45, 95% CI: 1.33–1.60 and 1.78 95% CI: 1.50–2.12, respectively). The risk of kidney cancer showed decreasing risk with cumulative metformin dose, however risk of kidney cancer remained higher than in general population in the highest cumulative metformin exposure group (SIRs 1.25, 95% CI: 1.07–1.46). Conclusions: The patients with type 2 diabetes have higher risk for kidney cancer compared with the general Lithuanian population
Internet: https://www.eusupplements.europeanurology.com/article/S1569-9056(19)32200-6/pdf
Affiliation(s): Lietuvos sveikatos mokslų universitetas
MA Medicinos fakultetas
Nacionalinis vėžio institutas
Vilniaus universitetas
Appears in Collections:Universiteto mokslo publikacijos / University Research Publications

Show full item record
Export via OAI-PMH Interface in XML Formats
Export to Other Non-XML Formats

Page view(s)

16
checked on Apr 1, 2020

Download(s)

2
checked on Apr 1, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.